Home / Brands / Legacy Pharmaceutical Packaging
Legacy Pharmaceutical Packaging Recalls
12 recalls on record · May 22, 2013 to January 3, 2024 · Drugs
Recalls by year
13
14
17
19
20
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
January 3, 2024DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for
Hazard: CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
October 7, 2020DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc
Hazard: Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
May 8, 2019DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202
Hazard: CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)
April 10, 2019DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202,
Hazard: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.
March 27, 2019DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 100 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, M
Hazard: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
March 27, 2019DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Man
Hazard: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
March 27, 2019DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 25 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Man
Hazard: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
March 29, 2017DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls ATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co., 1014 Vine Street, Cincinnati, OH
Hazard: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
June 18, 2014DrugsFDA
Legacy Pharmaceutical Packaging recalls Pantoprazole Sodium, Delayed-release tablets, USP, 40 mg tablets, 100 (10x10) unit dose packages, Manufactured by Dr. Re
Hazard: Correct Labeled Product Miscart/Mispack: some cartons labeled as Pantoprazole Sodium Delayed-Release may contain correctly labeled blister cards of Lorazepam tablets
May 7, 2014DrugsFDA
Legacy Pharmaceutical Packaging recalls Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactur
Hazard: Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
June 12, 2013DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60
Hazard: Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009
May 22, 2013DrugsFDA
Legacy Pharmaceutical Packaging LLC recalls Walmart Amlodipine Besylate Tablets, USP 10 mg, Rx only, 30 tablets, Manufactured by: InvaGen Pharmaceuticals, Inc., Hau
Hazard: Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description. Tablet strength is 10 mg.